Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Digiesi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Minerva Medica|October 15, 1987
[The combination of nifedipine and a low sodium diet with potassium supplement in the therapy of essential arterial hypertension]V Digiesi, P Parigi
Archivio Per Le Scienze Mediche|April 1, 1976
[Lysosomal lesions during a course of acute experimental muscular ischemia. Protective effect of a polypetitide proteinase inhibitor]V Digiesi, P Nassi, E Castigli
Minerva Medica|March 1, 1989
[The benefits of L-carnitine therapy in essential arterial hypertension with diabetes mellitus type II]V Digiesi, R Palchetti, F Cantini
Pain|December 1, 1975
Effect of a proteinase inhibitor on intermittent claudication or on pain at rest in patients with peripheral arterial diseaseV Digiesi, V Bartoli, B Dorigo
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 2, 2001
Prospects for the use of antioxidant therapy in hypertensionV Digiesi, M Lenuzza, G Digiesi
Biochemical Medicine|June 1, 1983
Magnesium in tumoral tissues, in the muscle and serum of subjects suffering from neoplasiaV Digiesi, R Bandinelli, P Bisceglie, et al.
Minerva Medica|July 31, 1986
[Hemorheologic and blood cell changes in humans during partial immersion, with a therapeutic method, in 38 C water]V Digiesi, G Cerchiai, L Mannini, et al.
La Clinica Terapeutica|May 1, 1994
L-carnitine adjuvant therapy in essential hypertensionV Digiesi, F Cantini, G Bisi, et al.
Angiology|July 1, 1975
Changes in enzyme levels in human skeletal muscle during obstructive arteriopathy of the lower limbsV Digiesi, P Nassi, P Cicchi, et al.
Minerva Medica|February 15, 1987
[Hormonal, beta-endorphin and renin activity changes in man during partial immersion, as a therapeutic method, in water at 38 degrees C]V Digiesi, G Cerchiai, S Forni, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Minerva Medica|October 15, 1987
[The combination of nifedipine and a low sodium diet with potassium supplement in the therapy of essential arterial hypertension]V Digiesi, P Parigi
Archivio Per Le Scienze Mediche|April 1, 1976
[Lysosomal lesions during a course of acute experimental muscular ischemia. Protective effect of a polypetitide proteinase inhibitor]V Digiesi, P Nassi, E Castigli
Minerva Medica|March 1, 1989
[The benefits of L-carnitine therapy in essential arterial hypertension with diabetes mellitus type II]V Digiesi, R Palchetti, F Cantini
Pain|December 1, 1975
Effect of a proteinase inhibitor on intermittent claudication or on pain at rest in patients with peripheral arterial diseaseV Digiesi, V Bartoli, B Dorigo
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 2, 2001
Prospects for the use of antioxidant therapy in hypertensionV Digiesi, M Lenuzza, G Digiesi
Biochemical Medicine|June 1, 1983
Magnesium in tumoral tissues, in the muscle and serum of subjects suffering from neoplasiaV Digiesi, R Bandinelli, P Bisceglie, et al.
Minerva Medica|July 31, 1986
[Hemorheologic and blood cell changes in humans during partial immersion, with a therapeutic method, in 38 C water]V Digiesi, G Cerchiai, L Mannini, et al.
La Clinica Terapeutica|May 1, 1994
L-carnitine adjuvant therapy in essential hypertensionV Digiesi, F Cantini, G Bisi, et al.
Angiology|July 1, 1975
Changes in enzyme levels in human skeletal muscle during obstructive arteriopathy of the lower limbsV Digiesi, P Nassi, P Cicchi, et al.
Minerva Medica|February 15, 1987
[Hormonal, beta-endorphin and renin activity changes in man during partial immersion, as a therapeutic method, in water at 38 degrees C]V Digiesi, G Cerchiai, S Forni, et al.
Pageof 2